AI/ML Medical Device Security for Imaging AI & SaMD
AI/ML security for imaging AI and SaMD - model integrity, PCCP-aligned change control, training-data governance, and adversarial-input testing.
Last reviewed March 2026 · Reviewed against the FDA Feb 3, 2026 final premarket cybersecurity guidance.
AI/ML security for imaging AI and SaMD is its own discipline because the model is the product, and the security boundaries are different from traditional software: training data lineage, model artifact integrity, inference-path adversarial robustness, and the Predetermined Change Control Plan (PCCP) as a security boundary. Our service for this segment covers all four, aligned to FDA's AI/ML PCCP guidance and the 2026 final premarket cybersecurity guidance.
We document model provenance and training-data lineage at the level reviewers now expect: dataset source, dedup and PHI-handling controls, train/test split integrity, and the audit trail that proves the deployed model came from the training data on file. We treat model artifacts as SBOM components with hash-pinned versioning and signed distribution. We test the inference path for clinically-plausible adversarial inputs (not academic perturbations - inputs in the distribution your device will actually see), confidence-suppression paths, and metadata-driven shortcuts. Most importantly, we security-model the PCCP itself: which model updates are allowed under the PCCP envelope, who authorizes them, and what stops an unauthorized model from being shipped under cover of an approved PCCP change. This is the question reviewers are starting to ask, and most submissions don't have an answer.
Layers we exercise in this engagement
The imaging & ai/samd system, from the outermost cloud and clinician surfaces down to the device itself. Highlighted layers are exercised by this ai/ml medical device security.
- 01Training data lineage Tested
- 02Model weights Tested
- 03Inference container Tested
- 04DICOM SR writeback Tested
- 05Clinician UI Tested
Layers shown outermost (top) to innermost (bottom). Dashed rows are part of the surrounding system but out of scope for this view.
AI/ML Medical Device Security engagement, end to end
Four phases, fixed fee, scoped to imaging & ai/samd architecture from kickoff onward.
-
01
Scope + kickoff
Architecture review, attack-surface walkthrough, and threat-model alignment with your team. Written scope in 24 hours.
-
02
Threat-model alignment
Every STRIDE entry in your threat model is matched to a planned test case so reviewers see one-to-one coverage.
-
03
Test execution
Device, cloud, mobile, BLE/RF, and OTA channels exercised in parallel by senior engineers - not a single web-app scan.
-
04
Reviewer-ready report + retest
eSTAR-format report with findings, CVSS, remediation, and unlimited retests until every finding is closed.
What we see in Imaging & AI/SaMD ai/ml medical device security
The patterns we hit in this segment, this service, again and again.
-
PCCP doesn't define the security envelope
PCCP defines clinical performance bounds. Security envelope (who can update, what's signed, what's audited) absent. Reviewer asks.
-
Model artifacts not signed or hash-pinned
Model files distributed via container build. No signature, no manifest hash. Substitution detectable only by training-data audit.
-
Training-data lineage not auditable
Data ingest pipeline manual; lineage reconstructable but not on file. Reviewer asks for documented chain of custody.
-
Confidence-suppression paths undocumented
Specific input metadata combinations cause max-confidence outputs without inference. Documented as 'edge case' in model card; security implications not addressed.
"Blue Goat Cyber takes the burden off our engineers and makes FDA cybersecurity requirements easy to understand. Their expertise and smooth process mean we can focus on our product, not the paperwork. The organized documentation, perfectly formatted for eSTAR, saves us countless hours."
Standard AI/ML Medical Device Security deliverables
The same deliverables the parent AI/ML Medical Device Security service ships with - tuned to your imaging & ai/samd architecture.
- Adversarial ML testing (evasion, poisoning, model inversion, prompt injection)
- PCCP authoring and FDA AI/ML transparency artifacts
- Model lifecycle, monitoring, and drift controls
- GMLP + AAMI CR34971 alignment
What lands in your eSTAR submission
Reviewer-format documents ready to drop straight into the cybersecurity attachments of your submission - no reformatting on your side.
- Adversarial ML testing (evasion, poisoning, model inversion, prompt injection)
- PCCP authoring and FDA AI/ML transparency artifacts
- Model lifecycle, monitoring, and drift controls
- GMLP + AAMI CR34971 alignment
Standards that apply
The Imaging & AI/SaMD baseline, plus the call-outs that matter for ai/ml medical device security in this segment.
Segment-specific call-outs
FDA AI/ML PCCP guidance + 2026 final premarket guidance
PCCP is a regulatory and a security boundary. Treat it as both.
NIST AI Risk Management Framework
Useful framing for training-data governance and model lifecycle controls reviewers are increasingly aligned with.
What's not in scope
We scope tightly on purpose. These items are either out-of-scope by design or belong in a separate engagement - we'll tell you up front, not after kickoff.
- Hospital enterprise IT network penetration testing
- Clinical efficacy or human-factors validation
- Physical security of manufacturing sites
- Source-code review (unless explicitly added as a separate engagement)
AI/ML Medical Device Security for Imaging & AI/SaMD - FAQs
The questions buyers in this segment actually ask before scoping a ai/ml medical device security engagement.
Go deeper on Imaging & AI/SaMD and premarket
A practical, ungated buyer's guide for medical device manufacturers evaluating cybersecurity partners, what goes wrong, why it costs you, and what to demand from your next engagement. Aligned to the FDA February 2026 premarket guidance.
The most common high- and critical-severity findings we surface in medical device penetration tests, what each one looks like in the field, and how to fix it before your FDA submission.
A practical, ungated guide to the threat modeling gaps that trigger FDA cybersecurity questions in 510(k), De Novo, and PMA submissions - and exactly how to close them before reviewers find them.
What happens if you fail an FDA cybersecurity inspection: the 483-to-consent-decree enforcement ladder and the commercial fallout for device makers.
FDA Section 524B applies to any new premarket submission for a cyber device, including legacy platforms. What attaches, what postmarket rules cover the rest.
SPDF vs SSDLC for medical devices. Why the FDA's Secure Product Development Framework demands more than a standard Secure SDLC, and what to add.
Other engagements for Imaging & AI/SaMD
Teams in this segment commonly bundle these alongside ai/ml medical device security.
Keep going
Scope a AI/ML Medical Device Security engagement for your imaging & ai/samd program.
A 30-minute call with a senior engineer who has done this in imaging & ai/samd before - not a sales rep.